Immunoregulatory cytokine release in rat spleen cell cultures after treatment with bleomycin and its analogues in vivo
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 33 (1) , 33-38
- https://doi.org/10.1007/bf01742525
Abstract
We have studied the immunological effects that accompany a change in the chemical structure of a group of antineoplastic antibiotics by comparing the immunoregulatory cytokine release during mitogen-stimulated spleen cell culture after in vivo drug treatment. Whereas bleomycin and peplomycin increased cytokine levels in culture supernatants when compared with supernatants from untreated control rat spleen cell cultures, liblomycin generally reduced cytokine levels under the same culture conditions. We then compared these results with the antitumor effects of equivalent doses of the three drugs against a highly antigenic rat fibrosarcoma, KMT-17, both in vivo and in vitro. The results suggest that the immunoaugmenting effects of these antitumor antibiotics are essential for an optimal antitumor effect in vivo, and that these effects can be drastically altered by modification of the chemical structure of the drugs employed.Keywords
This publication has 25 references indexed in Scilit:
- Effect of anticancer drugs on the release of tumour necrosis factor in vitroCancer Immunology, Immunotherapy, 1990
- Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation PathwayScience, 1989
- Fluorinated 4-quinolones induce hyperproduction of interleukin 2.Proceedings of the National Academy of Sciences, 1989
- Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitroCancer Immunology, Immunotherapy, 1989
- DNA cleavage activity of liblomycin (NK313), a novel analog of bleomycin.The Journal of Antibiotics, 1988
- Liblomycin, a new analogue of bleomycinCancer Treatment Reviews, 1987
- Enhancement of interleukin-2 release in rats by treatment with bleomycin and Adriamycin in vivoCancer Immunology, Immunotherapy, 1987
- Potentiation of release of interleukin-2 by bleomycinImmunopharmacology, 1986
- Potentiation of T-lymphocyte function by bleomycinImmunopharmacology, 1984
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983